Cargando…
Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series
OBJECTIVE: Alveolar echinococcosis (AE) is a parasitic liver disease with infiltrative growth similar to solid organ malignancies. Major vascular damage is frequent and often remains untreated until catastrophic events precipitate. Detailed clinical and radiological assessment is required to guide i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423801/ https://www.ncbi.nlm.nih.gov/pubmed/37567730 http://dx.doi.org/10.1136/bmjgast-2023-001181 |
_version_ | 1785089527400890368 |
---|---|
author | Gieser, Paula Merle, Uta Junghanss, Thomas Weber, Tim F Stojković, Marija |
author_facet | Gieser, Paula Merle, Uta Junghanss, Thomas Weber, Tim F Stojković, Marija |
author_sort | Gieser, Paula |
collection | PubMed |
description | OBJECTIVE: Alveolar echinococcosis (AE) is a parasitic liver disease with infiltrative growth similar to solid organ malignancies. Major vascular damage is frequent and often remains untreated until catastrophic events precipitate. Detailed clinical and radiological assessment is required to guide individualised treatment decisions. Standardised radiological reporting templates of malignancies with profiles resembling AE are candidates for adaptation. Our objectives are to describe vascular pathology in AE and establish a framework for structured evaluation as the basis for treatment decisions and monitoring. DESIGN: Retrospective case series. RESULTS: 69 patients (37.1%) had vascular involvement: portal vein (PV) 24.7%, hepatic vein (HV) 22.6% inferior vena cava (IVC) 13.4%. Significant stenosis/occlusion of vessels was present in 15.1% of PV, in 13.4% of HV and in 7.5% of IVC involvement. Vascular pathology needing specific treatment or monitoring was present in 8.6% of patients. The most frequent clinical presentation was high grade IVC stenosis or occlusion which was seen in 11 patients of the cohort. CONCLUSION: Advanced AE requires early multidisciplinary assessment to prevent progressive impairment of liver function due to vascular damage. The focus at first presentation is on complete evaluation of vascular (and biliary) involvement. The focus in non-resectable AE is on prevention of vascular (and biliary) complications while suppressing growth of AE lesions by benzimidazole treatment to improve the quality of life of patients. We developed a framework for standardised vascular assessment and follow-up of patients with AE to recognise and treat complications early. |
format | Online Article Text |
id | pubmed-10423801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-104238012023-08-15 Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series Gieser, Paula Merle, Uta Junghanss, Thomas Weber, Tim F Stojković, Marija BMJ Open Gastroenterol Infection OBJECTIVE: Alveolar echinococcosis (AE) is a parasitic liver disease with infiltrative growth similar to solid organ malignancies. Major vascular damage is frequent and often remains untreated until catastrophic events precipitate. Detailed clinical and radiological assessment is required to guide individualised treatment decisions. Standardised radiological reporting templates of malignancies with profiles resembling AE are candidates for adaptation. Our objectives are to describe vascular pathology in AE and establish a framework for structured evaluation as the basis for treatment decisions and monitoring. DESIGN: Retrospective case series. RESULTS: 69 patients (37.1%) had vascular involvement: portal vein (PV) 24.7%, hepatic vein (HV) 22.6% inferior vena cava (IVC) 13.4%. Significant stenosis/occlusion of vessels was present in 15.1% of PV, in 13.4% of HV and in 7.5% of IVC involvement. Vascular pathology needing specific treatment or monitoring was present in 8.6% of patients. The most frequent clinical presentation was high grade IVC stenosis or occlusion which was seen in 11 patients of the cohort. CONCLUSION: Advanced AE requires early multidisciplinary assessment to prevent progressive impairment of liver function due to vascular damage. The focus at first presentation is on complete evaluation of vascular (and biliary) involvement. The focus in non-resectable AE is on prevention of vascular (and biliary) complications while suppressing growth of AE lesions by benzimidazole treatment to improve the quality of life of patients. We developed a framework for standardised vascular assessment and follow-up of patients with AE to recognise and treat complications early. BMJ Publishing Group 2023-08-11 /pmc/articles/PMC10423801/ /pubmed/37567730 http://dx.doi.org/10.1136/bmjgast-2023-001181 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Infection Gieser, Paula Merle, Uta Junghanss, Thomas Weber, Tim F Stojković, Marija Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
title | Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
title_full | Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
title_fullStr | Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
title_full_unstemmed | Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
title_short | Vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
title_sort | vascular pathology in patients with alveolar echinococcosis: framework for assessment and clinical management – a retrospective case series |
topic | Infection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423801/ https://www.ncbi.nlm.nih.gov/pubmed/37567730 http://dx.doi.org/10.1136/bmjgast-2023-001181 |
work_keys_str_mv | AT gieserpaula vascularpathologyinpatientswithalveolarechinococcosisframeworkforassessmentandclinicalmanagementaretrospectivecaseseries AT merleuta vascularpathologyinpatientswithalveolarechinococcosisframeworkforassessmentandclinicalmanagementaretrospectivecaseseries AT junghanssthomas vascularpathologyinpatientswithalveolarechinococcosisframeworkforassessmentandclinicalmanagementaretrospectivecaseseries AT webertimf vascularpathologyinpatientswithalveolarechinococcosisframeworkforassessmentandclinicalmanagementaretrospectivecaseseries AT stojkovicmarija vascularpathologyinpatientswithalveolarechinococcosisframeworkforassessmentandclinicalmanagementaretrospectivecaseseries |